Visual Analog Scale

视觉模拟量表
  • 文章类型: Journal Article
    目的:越来越多的研究探讨针灸治疗痛性糖尿病周围神经病变(PDPN)的疗效,但是这些研究的发现产生了相互矛盾的结果。因此,本研究旨在评估针灸治疗PDPN的疗效,从而提供更有说服力的结果。
    方法:系统搜索了7个数据库中直到2023年12月1日发表的研究。纳入所有针刺治疗PDPN的随机对照试验(RCT),疼痛视觉模拟评分(VAS)。研究选择,数据提取,和评估由研究人员独立进行。采用偏倚风险2(RoB2)工具评估偏倚风险。从这个样本中,平均差(MD),95%置信区间(CI),出版偏见,然后计算异质性。
    结果:与常规护理组相比,手动针刺组的疼痛VAS评分显着降低(p<0.0001;MD=-1.45[95%CI,-1.97至-0.93],I2=84%)。与假针刺组相比,真实针刺组的VAS评分降低更大(p=0.004;MD=-0.97[95%CI,-1.63至-0.31],I2=65%)。此外,针刺组感觉神经传导速度改善(SNCV,p<0.0001;MD=2.29[95%CI,1.79至2.78],I2=14%)以及运动神经传导速度(MNCV,p<0.0001;MD=2.87[95%CI,2.46至3.27],I2=0)。不同持续时间的针灸治疗,包括6-10周和3-4周,与常规护理组相比,VAS评分显着降低。
    结论:这项荟萃分析为针灸有可能缓解PDPN症状并改善SNCV和MNCV提供了初步证据。然而,需要高质量的随机对照试验来提供进一步的证据,从而更好地证实这一论点.
    OBJECTIVE: A growing number of studies have investigated the efficacy of acupuncture in the treatment of painful diabetic peripheral neuropathy (PDPN), but the findings of these studies have generated conflicting results. This study therefore aimed to assess the efficacy of acupuncture for treating PDPN so as to offer more conclusive results.
    METHODS: Seven databases were systematically searched for studies published up until December 1, 2023. All randomized controlled trials (RCTs) of acupuncture for PDPN with visual analog scale (VAS) for pain score were included. Study selection, data extraction, and evaluation were conducted independently by researchers. The Risk of Bias 2 (RoB2) tool was employed to assess the risk of bias. From this sample, the mean difference (MD), 95 % confidence intervals (CI), publication bias, and heterogeneity were then computed.
    RESULTS: The manual acupuncture group exhibited a significant decrease in the VAS for pain score compared with the routine care group (p < 0.0001; MD = -1.45 [95 % CI, -1.97 to -0.93], I2 = 84 %). The real acupuncture group demonstrated a greater reduction in VAS scores than the sham acupuncture group (p = 0.004; MD = -0.97 [95 % CI, -1.63 to -0.31], I2 = 65 %). Additionally, the acupuncture group showed improvements in sensory nerve conduction velocity (SNCV, p < 0.0001; MD = 2.29 [95 % CI, 1.79 to 2.78], I2 = 14 %) as well as motor nerve conduction velocity (MNCV, p < 0.0001; MD = 2.87 [95 % CI, 2.46 to 3.27], I2 = 0). Different durations of acupuncture treatment, including 6-10 weeks and 3-4 weeks, demonstrated a significant reduction in VAS scores compared with the routine care group.
    CONCLUSIONS: This meta-analysis provides preliminary evidence for the claim that acupuncture has the potential to alleviate PDPN symptoms and improve SNCV and MNCV. However, high-quality RCTs are needed to offer further evidence and thus better substantiate such a contention.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:解剖全肩关节置换术(aTSA)和反向全肩关节置换术(rTSA)后的恢复有许多相似之处;但是,最近,外科医生认为,与aTSA患者相比,接受rTSA的患者术后过程难度较小,疼痛较少。鉴于人们对术后疼痛控制和阿片类药物消耗的认识提高,以及rTSA的适应症不断扩大,我们试图确定aTSA和rTSA患者术后12周疼痛和阿片类药物用量的差异.
    方法:进行回顾性分析,以确定2013年1月至2018年4月在单一机构接受原发性aTSA或rTSA的所有患者。纳入记录了视觉模拟量表(VAS)和美国肩肘外科医生(ASES)评分的患者进行分析。排除了翻修性关节置换术。术前和标准2周记录VAS评分,6周,术后12周时间点。P值<0.05被认为具有统计学意义,除了应用Bonferroni校正的地方。
    结果:共有690例患者接受了TSA(278aTSA,412rTSA)。术前,aTSA和rTSA患者组的VAS评分相似(6vs6,P=0.38)。术后,在为期6周的访问中,aTSA组的VAS较高,与rTSA患者相比(2.8vs2.2,P=0.003)。ATSA患者仍在阿片类药物在2周(62.4%vs45.6%,P=<0.001)时间段。ATSA患者需要更多的阿片类药物处方补充前2周(61.7%vs45.5%,P=<0.001)和6周(40.4%vs30.7%,P=0.01)随访。
    结论:尽管术前VAS和阿片类药物使用率相似,aTSA患者需要更多的阿片类药物再填充,并在术后早期保持阿片类药物更长的时间,以实现类似的术后疼痛控制,如类似的VAS所示。这项研究表明,与VAS和阿片类药物消耗所表明的aTSA相比,从rTSA中的回收难度较小。
    BACKGROUND: Recovery after anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA) has many similarities; however, recently surgeons have suggested patients undergoing rTSA have a less difficult postoperative course with less pain compared with aTSA patients. Given the heightened awareness to postoperative pain control and opioid consumption, as well as the expanding indications for rTSA, we sought to determine the differences in pain and opioid consumption between aTSA and rTSA patients in a 12-week postoperative period.
    METHODS: A retrospective chart review was performed to identify all patients who underwent a primary aTSA or rTSA from January 2013 to April 2018 at a single institution. Patients with recorded visual analog scale (VAS) and American Shoulder and Elbow Surgeons (ASES) scores were included for analysis. Revision arthroplasties were excluded. VAS scores were recorded preoperatively and at standard 2-week, 6-week, and 12-week postoperative time points. P-values < 0.05 were considered statistically significant, except where Bonferroni corrections were applied.
    RESULTS: A total of 690 patients underwent TSA (278 aTSA, 412 rTSA). Preoperatively, aTSA and rTSA patient groups had similar VAS scores (6 vs 6, P = 0.38). Postoperatively, the aTSA group had a higher VAS at the 6-week visit, compared with rTSA patients (2.8 vs 2.2, P = 0.003). aTSA patients remained on opioids at a higher rate at the 2-week (62.4% vs 45.6%, P = < 0.001) time period. aTSA patients needed more opioid prescription refills before the 2-week (61.7% vs 45.5%, P = <0.001) and 6-week (40.4% vs 30.7%, P = 0.01) follow-up visits.
    CONCLUSIONS: Despite similar preoperative VAS and rates of preoperative opioid use, aTSA patients required more opioid medication refills and remained on opioids for a longer duration in the early postoperative period to achieve similar postoperative pain control as indicated by similar VAS. This study suggests that the recovery from rTSA is less difficult compared with aTSA as indicated by VAS and opioid consumption.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Meta-Analysis
    背景:目前的研究探讨了omega-3多不饱和脂肪酸(PUFA)对食欲的影响。
    目的:使用对照临床试验(CT)的系统评价和荟萃分析,研究ω-3多不饱和脂肪酸(n-3PUFA)对食欲的影响。
    方法:在线数据库,包括PubMed、Scopus,ISIWebofScience,和谷歌学者被搜索到2022年1月。使用随机效应模型来比较补充n-3PUFA和对照个体之间的食欲评分的总体标准化平均差异。
    结果:我们的系统评价包括15个符合条件的CTs和1504个参与者(补充n-3PUFA872个和安慰剂组632个)。荟萃分析显示,补充n-3PUFA的总食欲评分与对照组之间没有显着差异(标准化平均差[SMD]=0.458,95%置信区间[CI]-0.327,1.242,P值=0.25)。然而,与对照组相比,补充n-3PUFA显着增加了进食欲望(SMD=1.07,95%CI0.116,2.029,P=0.02)。
    结论:尽管我们发现补充omega-3对总体食欲评分没有影响,它适度地增加了吃的欲望。仍需要进一步的CT评估PUFA对食欲的影响以证实这些发现。
    The current studies explore the effect of omega-3 polyunsaturated fatty acids (PUFAs) on appetite.
    To examine the effect of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on appetite using a systematic review and meta-analysis of controlled clinical trials (CTs).
    Online databases including PubMed, Scopus, ISI Web of Science, and Google Scholar were searched up to January 2022. A random-effects model was used to compare the overall standardized mean difference in appetite scores between n-3 PUFAs supplemented and control individuals.
    Fifteen eligible CTs with 1504 participants (872 for n-3 PUFA supplementation and 632 for placebo groups) were included in our systematic review. The meta-analysis showed no significant difference in overall appetite score between n-3 PUFAs supplemented and control groups (standardized mean difference [SMD] = 0.458, 95% confidence interval [CI] - 0.327, 1.242, P value = 0.25). However, the n-3 PUFA supplementation significantly increased the desire to eat (SMD = 1.07, 95% CI 0.116, 2.029, P = 0.02) compared to control.
    Although we found no effect of omega-3 supplementation on overall appetite score, it modestly increases the desire to eat. Further CTs evaluating the effect of PUFAs on appetite are still needed to confirm these findings.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Systematic Review
    阴部神经阻滞(PNB)是一种常用的麻醉方法,近年来已广泛用于痔疮的术后镇痛。因此,我们对双盲随机对照试验(RCT)进行了系统评价和荟萃分析,以分析PNB在痔疮术后镇痛中的有效性.
    从成立到2023年8月14日发表的相关数据和研究是从PubMed检索的,Embase,和WebofScience评估PNB用于痔疮切除术后镇痛的有益效果。
    该荟萃分析包括6个包含501名患者的双盲随机对照试验。我们评估了PNB在改善痔疮术后镇痛效果方面的功能。术后6小时内视觉模拟评分(VAS)评分(MD,-3.04;95%CI,-4.13至-1.95;P<0.0001),12小时(MD,-3.14;95%CI,-3.87至-2.40;P<0.0001),和24小时(MD,-2.25;95%CI,-2.95至-1.55;P<0.0001)通过应用PNB增强,但不是在48小时内(MD,-2.54;95%CI,-5.29至0.20;P=0.07)。
    阴部神经阻滞(PNB)能有效缓解痔疮术后疼痛。然而,我们的结果仍需要多中心临床研究的证实.
    UNASSIGNED: Pudendal nerve block (PNB) is a commonly used anesthesia method that has been widely used in postoperative analgesia for hemorrhoids in recent years. Therefore, we conducted a systematic review and meta-analysis of double-blind randomized controlled trials (RCTs) to analyze the effectiveness of PNB in postoperative analgesia for hemorrhoids.
    UNASSIGNED: Relevant data and studies published from inception until August 14, 2023, were retrieved from PubMed, Embase, and Web of Science to evaluate the beneficial effects of PNB for analgesia following hemorrhoidectomy.
    UNASSIGNED: This meta-analysis included 6 double-blind RCTs comprising 501 patients. We evaluated the function of PNB in improving outcomes of postoperative analgesia of hemorrhoids. Visual analogue scale (VAS) scores on postoperative within 6 h (MD, -3.04; 95% CI, -4.13 to -1.95; P < 0.0001), 12 h (MD, -3.14; 95% CI, -3.87 to -2.40; P < 0.0001), and 24 h (MD, -2.25; 95% CI, -2.95 to -1.55; P < 0.0001) were enhanced by the application of PNB, but not in 48 h (MD, -2.54; 95% CI, -5.29 to 0.20; P = 0.07).
    UNASSIGNED: Pudendal nerve block (PNB) could effectively relieve postoperative pain of hemorrhoids. However, our results still need to be confirmed by multi-center clinical studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这项研究的目的是比较前锯肌平面阻滞(SAPB)和胸段硬膜外镇痛(TEA)在胸外科手术中的有效性和安全性。
    我们对PubMed进行了系统搜索,ScienceDirect,Scopus,和WebofScience,并通过灰色文献对所有比较SAPB的随机对照试验,一种新型的胸壁神经阻滞,和TEA在手术中。评估的结果包括视觉模拟量表(VAS),低血压,术后恶心呕吐(PONV)。审核经理,5.4.1版本,用于统计分析。
    汇总分析包括六项符合纳入标准的试验。总共384例,手术接受了区域性阻滞(162-SAPB和163-TEA)。SAPB和TEA之间的VAS没有显着差异,平均差0.71,P=0.08。SAPB和TEA之间的PONV发生率没有显着差异(比值比=0.25,P=0.07)。与TEA相比,SAPB的低血压发生率较低(比值比=0.10,P=0.0001)。
    SAPB在胸外科手术的疼痛管理中产生了与TEA相当的VAS。SAPB的低血压发生率低于TEA。没有观察到PONV发生率的差异。在胸外科手术中,SAPB可以替代TEA。
    UNASSIGNED: The objective of this study was to compare the efficacy and safety of serratus anterior plane block (SAPB) and thoracic epidural analgesia (TEA) in thoracic region surgery.
    UNASSIGNED: We implemented a systematic search of PubMed, ScienceDirect, SCOPUS, and Web of Science and through gray literature for all randomized controlled trials that compared SAPB, a novel thoracic wall nerve block, and TEA in surgery. The evaluated outcomes included the Visual Analog Scale (VAS), hypotension, and postoperative nausea and vomiting (PONV). Review Manager, version 5.4.1, was implemented for the analysis of statistics.
    UNASSIGNED: The pooled analysis included six trials that fulfilled the inclusion criteria. In total 384, surgery had received regional blocks (162 - SAPB and 163 - TEA). VAS did not differ significantly between SAPB and TEA, with a mean difference of 0.71, P = 0.08. PONV incidence did not differ significantly between SAPB and TEA (odds ratio = 0.25, P = 0.07). Hypotension incidence was lower in SAPB compared to TEA (odds ratio = 0.10, P = 0.0001).
    UNASSIGNED: SAPB yielded comparable VAS with TEA in pain management of thoracic region surgery. The incidence of hypotension was lower in SAPB than in TEA. No difference in PONV incidence was observed. SAPB can be a viable alternative to TEA in thoracic region surgery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    慢性腰背痛(CLBP)是一个普遍的全球健康问题,导致长期不适和功能限制。温泉水疗,利用富含矿物质的,温暖的泉水,提供了一种独特的物理治疗,有望缓解CLBP症状。
    这项荟萃分析旨在评估温泉水疗在改善CLBP症状方面的有效性,包括疼痛强度,功能性残疾,生活质量,和药物使用。
    通过在多个数据库中检索相关文献进行系统评价和荟萃分析。纳入的研究比较了温泉水疗与对照干预或其他治疗方法。计算疼痛强度的标准化平均差(SMD)和95%置信区间(CI)。功能性残疾,药物使用,和生活质量。
    共有16项研究符合纳入标准,涉及来自不同国家的1656名慢性腰背痛患者。荟萃分析表明,温泉水疗可有效降低疼痛强度(SMD=-0.901,95%CI[-1.777,-0.025],P<0.05)和改善功能障碍(SMD=-3.236,95%CI[-4.898,-1.575],CLBP患者P<0.0001)。温泉水疗也导致药物使用显着减少(P<0.05)。亚组分析显示,温泉水疗效果在60岁及以上患者中更为明显,虽然在60岁以下的患者中没有观察到显著差异,单一温泉水疗有助于提高患者的生活质量。
    温泉水疗是改善CLBP症状的有效干预措施,包括疼痛强度,功能性残疾,和药物使用。它对60岁及以上的CLBP患者特别有益。这些发现支持将温泉水疗整合到CLBP的治疗方法中,尽管需要进一步的研究来确定其在年轻患者中的疗效,并探索其治疗效果的潜在机制。
    CRD42023430860。
    UNASSIGNED: Chronic Low Back Pain (CLBP) is a prevalent global health issue, leading to prolonged discomfort and functional limitations. Hot spring hydrotherapy, which utilizes mineral-rich, warm spring water, offers a unique physical therapy that holds promise in alleviating CLBP symptoms.
    UNASSIGNED: This meta-analysis aims to assess the effectiveness of hot spring hydrotherapy in improving CLBP symptoms, encompassing pain intensity, functional disability, quality of life, and medication usage.
    UNASSIGNED: A systematic review and meta-analysis were conducted by searching relevant literature in multiple databases. Included studies compared hot spring hydrotherapy with control interventions or other treatments. Standardized mean differences (SMD) with 95% confidence intervals (CI) were calculated for pain intensity, functional disability, medication usage, and quality of life.
    UNASSIGNED: A total of 16 studies met the inclusion criteria, involving 1656 participants with chronic low back pain across various countries. The meta-analysis demonstrated that hot spring hydrotherapy was effective in reducing pain intensity (SMD = -0.901, 95% CI [-1.777, -0.025], P < 0.05) and improving functional disability (SMD = -3.236, 95% CI [-4.898, -1.575], P < 0.0001) in CLBP patients. Hot spring hydrotherapy also resulted in a significant reduction in medication usage (P < 0.05). Subgroup analysis showed that the effects of hot spring hydrotherapy were more pronounced in patients aged 60 and above, while no significant differences were observed in patients below 60 years of age, single hot Spring Hydrotherapy help improve patients\' quality of life.
    UNASSIGNED: Hot spring hydrotherapy is an effective intervention for improving CLBP symptoms, including pain intensity, functional disability, and medication usage. It is particularly beneficial for CLBP patients aged 60 and above. These findings support the integration of hot spring hydrotherapy into the treatment approach for CLBP, although further research is needed to determine its efficacy in younger patients and to explore the underlying mechanisms of its therapeutic effects.
    UNASSIGNED: CRD42023430860.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • DOI:
    文章类型: Journal Article
    背景:早期膝骨性关节炎(OA)治疗是多模式的,通常使用的物理治疗和药物治疗。虽然受欢迎,诸如葡糖胺和双醋瑞因之类的口服补充剂尚未被报道具有高功效。未变性的II型胶原蛋白(UC-II)已被引入用于早期OA的治疗;它有助于软骨修复和保存。本综述旨在确定其在疼痛缓解和膝关节功能方面的功效。
    方法:在MEDLINE(PubMed)上进行了系统的文献检索,Embase,Scopus,和Cochrane图书馆的已发表文献;包括比较UC-II补充与安慰剂/对照在成人早期膝关节OA中的结果的研究。评估的结果是VAS评分,生活质量-西安大略省和麦克马斯特大学(WOMAC分数),膝关节功能,膝关节运动范围,以及治疗过程中的任何并发症。
    结果:经过初步搜索,共获得293个结果;最终纳入8个随机对照试验(RCT)。共有243名患者接受UC-II补充(男性91名,女性152名)。在所有纳入研究中,干预组的总体平均年龄为53.5±0.99至68.7±5.3岁,平均随访时间为3~6个月。与安慰剂相比,UC-II的WOMAC和VAS评分等结果指标显示出更好的结果。步行测量值从基线显着改善,反映在改进的定时上行和上行和6分钟步行测试(6MWT)。总体并发症与其他补充剂相似。
    结论:由于文献有限,UC-II已显示出有望作为早期膝关节OA的有效补充,具有良好的疼痛缓解和改善的功能。然而,需要进一步的大规模研究来证实这些发现.
    BACKGROUND: Early knee osteoarthritis (OA) treatment is multimodal, with physical therapy and pharmacotherapy commonly used. Although popular, oral supplements like glucosamine and diacerein have not been reported to have high efficacy. Undenatured collagen type II (UC-II) has been introduced for therapy in early OA; it helps in cartilage repair and preservation. The present review was done to ascertain its efficacy in pain relief and knee function.
    METHODS: A systematic literature search was performed on MEDLINE (PubMed), Embase, Scopus, and Cochrane Library for published literature; studies comparing the outcome of UC-II supplementation with placebo/control in adult humans with early knee OA were included. The outcomes evaluated were VAS Score, quality of life - Western Ontario and McMaster Universities (WOMAC-score), Knee function, Knee range of motion, and any complications during the course of treatment.
    RESULTS: A total of 293 results were obtained after a primary search; 8 randomized control trials (RCT) were finally included. A total of 243 patients received UC-II supplementation (91 men and 152 women). The overall mean age range for the intervention group was 53.5±0.99 to 68.7±5.3 years across all included studies, and the mean follow-up duration was 3 to 6 months. Outcome measures like WOMAC and VAS scores showed better outcomes with UC-II in comparison to placebo. Walking measurements improved significantly from the baseline, reflected in improved timed up-and-go and 6-minute walk tests (6MWT). The overall complications were similar to other supplements.
    CONCLUSIONS: With limited literature, UC-II has shown promise as a potent supplement in early knee OA with good pain relief and improved function. However, further large-scale studies are needed to substantiate these findings.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Meta-Analysis
    目的:本研究旨在评估临床结局,并发症发生率,可行性,经椎弓根保留入路治疗胸椎间盘突出症的适用性。
    方法:我们搜索了三个数据库,包括Cochrane库,PubMed,和Embase的合格研究,直到2022年12月。使用非随机研究的方法学指标评估研究质量及其偏倚风险。我们使用I2统计量和P值评估了研究之间的异质性。
    结果:从2009年到2022年,共发表了11篇纳入文章中描述的328例患者。在四项研究中报告了使用视觉模拟量表(VAS评分)的疼痛结果。标准化平均差异报告为0.749(CI95%0.555-0.943)。所获得的结果显示了手术的积极作用和术后患者疼痛的改善。5项研究报告了使用Nurick评分的脊髓病结局。标准化平均差异报告为0.775(CI95%0.479-1.071)。结果表明了该方法的积极作用。八项研究评估了术后并发症和神经系统恶化。合并的总并发症为12.4%(32/258)和3.5%(9/258)神经系统恶化。
    结论:这项研究的结果表明,保留椎弓根的经切面入路对胸椎间盘突出症手术患者的临床结局具有积极作用。该技术已被证明对正确的患者是安全有效的。与其他手术方法相比,该技术的并发症发生率较低,住院时间较短。这些信息可以帮助临床医生在为胸椎间盘突出症患者选择最合适的手术技术时做出明智的决定。
    OBJECTIVE: This study aimed to evaluate the clinical outcomes, complication rate, feasibility, and applicability of transfacet pedicle-sparing approach for treating thoracic disc herniation.
    METHODS: We searched three databases including the Cochrane Library, PubMed, and Embase for eligible studies until Dec 2022. The quality of studies and their risk of bias were assessed using the methodological index for non-randomized studies. We evaluated the heterogeneity between studies using the I2 statistic and the P-value for the heterogeneity.
    RESULTS: A total of 328 patients described in 11 included articles were published from 2009 to 2022. Pain outcomes using the visual analog scale (VAS score) were reported in four studies. The standardized mean difference was reported as 0.749 (CI 95% 0.555-0.943). The obtained result showed the positive effect of the procedure and the improvement of patients\' pain after the surgery. Myelopathy outcomes using the Nurick score were reported in five studies. The standardized mean difference was reported as 0.775 (CI 95% 0.479-1.071). The result showed the positive effect of the procedure. Eight studies assessed postoperative complications and neurological deterioration. The pooled overall complication was 12.4% (32/258) and 3.5% (9/258) neurological worsening.
    CONCLUSIONS: The results of this study demonstrated a positive effect of the transfacet pedicle-sparing approach on the clinical outcomes of patients with thoracic disc herniation surgery. The technique has been shown to be safe and effective for the right patient. The technique is associated with lower rates of complications and a shorter hospital stay compared to other surgical approaches. This information can assist clinicians in making informed decisions when selecting the most appropriate surgical technique for their patients with thoracic disc herniation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    尿石症的发病率逐年上升。输尿管支架是这种情况的流行治疗选择。改进支架的材料和结构以增加舒适度和减少并发症的努力导致了磁性支架的引入。
    评估磁性和常规支架在去除效率和安全性方面的差异。
    本研究是根据系统评价和荟萃分析(PRISMA)的首选报告项目进行和报告的。根据PRISMA原则提取数据。我们收集并结合了有关磁性支架与常规支架的随机对照试验的数据,以评估其移除效率和相关效果。使用RevMan5.4.1进行数据合成,并使用I2检验评估异质性。还进行了敏感性分析。关键指标包括支架移除时间,视觉模拟量表(VAS)疼痛评分,不同领域的输尿管支架症状问卷(USSQ)评分。
    七项研究被纳入审查。我们发现磁性支架的取出时间较短(平均差[MD]-8.28分钟,95%置信区间[CI]-15.6至-0.95;p=0.03),它们的去除与较少的疼痛相关(MD-3.01分,与常规支架相比,95%CI-3.83至-2.19;p<0.01)。磁性支架的尿液症状和性问题的USSQ评分高于常规支架。支架类型之间没有其他差异。
    磁性输尿管支架具有移除时间短的优点,去除过程中疼痛减轻,与传统支架相比,成本低。
    对于接受泌尿系结石治疗的患者,称为支架的细管通常暂时插入肾脏和膀胱之间的管中,以允许结石通过。磁性支架可以在不需要第二外科手术的情况下被移除。我们对两种类型支架的比较研究的回顾表明,磁性支架在移除过程中的效率和舒适性方面优于常规支架。
    UNASSIGNED: The incidence of urolithiasis is increasing year by year. Ureteral stents are a popular treatment option for this condition. Efforts to improve the material and structure of stents to increase comfort and reduce complications have led to the introduction of magnetic stents.
    UNASSIGNED: To evaluate differences in removal efficiency and safety for magnetic and conventional stents.
    UNASSIGNED: This study was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Data were extracted according to the PRISMA principles. We collected and combined data from randomized controlled trials on magnetic versus conventional stents to evaluate the efficiency of their removal and the associated effects. Data synthesis was performed using RevMan 5.4.1 and heterogeneity was evaluated using I2 tests. A sensitivity analysis was also performed. Key metrics included the stent removal time, Visual Analog Scale (VAS) pain scores, and Ureteral Stent Symptom Questionnaire (USSQ) scores for various domains.
    UNASSIGNED: Seven studies were included in the review. We found that magnetic stents had a shorter removal time (mean difference [MD] -8.28 min, 95% confidence interval [CI] -15.6 to -0.95; p = 0.03) and their removal was associated with less pain (MD -3.01 points, 95% CI -3.83 to -2.19; p < 0.01) in comparison to conventional stents. USSQ scores for urinary symptoms and sexual matters were higher for magnetic than for conventional stents. There were no other differences between the stent types.
    UNASSIGNED: Magnetic ureteral stents have the advantages of a shorter removal time, less pain during removal, and low cost in comparison to conventional stents.
    UNASSIGNED: For patients undergoing treatment of urinary stones, a thin tube called a stent is often temporarily inserted in the tube between the kidney and the bladder to allow stones to pass. Magnetic stents can be removed without any need for a second surgical procedure. Our review of studies comparing two types of stents suggests that magnetic stents are superior to conventional stents in terms of efficiency and comfort during removal.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:这项系统综述和荟萃分析研究评估了普拉提对慢性下腰痛患者疼痛和残疾的影响。
    方法:在2012年1月至2022年12月之间检索了六个电子数据库。从这些数据库中,仅选择了随机对照试验.选择使用PEDro量表评估方法学质量的标准。使用Cochrane偏差风险工具RoB2.0评估偏差风险。此外,本分析的主要结局是疼痛和残疾.
    结果:相应的结果证实,普拉提训练导致疼痛的显着改善(视觉模拟量表:加权平均差=-29.38,95%置信区间,-33.24至-25.52,I²值=56.70%;疼痛数字评分量表:加权平均差=-2.12,95%置信区间,-2.54至-1.69,I²值=0.00%)和残疾(罗兰-莫里斯残疾指数:加权平均差=-4.73,95%置信区间,-5.45至-4.01,I²值=41.79%)。完成普拉提训练六个月后,疼痛的改善(疼痛数值评定量表:加权平均差=-1.67,95%置信区间,-2.03至-1.32,I²值=0.00%)和残疾(罗兰-莫里斯残疾指数:加权平均差=-4.24,95%置信区间,-5.39至-3.09,I²值=52.79%)保持不变。
    结论:普拉提训练可能是改善慢性下腰痛患者疼痛和残疾的有效策略。
    OBJECTIVE: This systematic review and meta-analysis study evaluated the effects of Pilates on pain and disability in patients with chronic low back pain.
    METHODS: Six electronic databases were searched between January 2012 and December 2022. From these databases, only randomized controlled trials were selected. The criteria for assessing methodological quality using the PEDro scale were selected. The risk of bias was assessed using the Cochrane Risk of Bias Tool RoB 2.0. Additionally, the primary outcomes were pain and disability in this analysis.
    RESULTS: The corresponding results confirmed that Pilates training led to a significant improvement in pain (Visual Analog Scale: weighted mean difference = -29.38, 95% confidence interval, -33.24 to -25.52, I² value = 56.70%; Pain Numerical Rating Scale: weighted mean difference = -2.12, 95% confidence interval, -2.54 to -1.69, I² value = 0.00%) and disability (Roland- Morris Disability Index: weighted mean difference = -4.73, 95% confidence interval, -5.45 to -4.01, I² value = 41.79%). Six months after completion of Pilates training, the improvement in pain (Pain Numerical Rating Scale: weighted mean difference = -1.67, 95% confidence interval, -2.03 to -1.32, I² value = 0.00%) and disability (Roland-Morris Disability Index: weighted mean difference = -4.24, 95% confidence interval, -5.39 to -3.09, I² value = 52.79%) was maintained.
    CONCLUSIONS: Pilates training may be an effective strategy to improve pain and disability in patients with chronic low back pain.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号